These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2576441)

  • 1. Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin.
    Jones C; Burton MA; Gray BN
    J Pharm Pharmacol; 1989 Dec; 41(12):813-6. PubMed ID: 2576441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of albumin and casein microspheres as a carrier for doxorubicin.
    Chen Y; Willmott N; Anderson J; Florence AT
    J Pharm Pharmacol; 1987 Dec; 39(12):978-85. PubMed ID: 2894445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition.
    Cummings J; Willmott N; Marley E; Smyth J
    Biochem Pharmacol; 1991 Jun; 41(12):1849-54. PubMed ID: 2039540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres.
    Willmott N; Cummings J; Florence AT
    J Microencapsul; 1985; 2(4):293-304. PubMed ID: 3939779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
    Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
    J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immobilization of active urokinase on albumin microspheres: use of a chemical dehydrant and process monitoring.
    Bhargava K; Ando HY
    Pharm Res; 1992 Jun; 9(6):776-81. PubMed ID: 1409360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration.
    Kerr DJ; Willmott N; McKillop JH; Cummings J; Lewi HJ; McArdle CS
    Cancer; 1988 Sep; 62(5):878-83. PubMed ID: 3409170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged release of tegafur from S/O/W multiple emulsion.
    Oh I; Kang YG; Lee YB; Shin SC; Kim CK
    Drug Dev Ind Pharm; 1998 Oct; 24(10):889-94. PubMed ID: 9876543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An experirmental study on the preparation and drug sustained release characteristics of Pingyangmycin Albumin Microspheres].
    Gao QH; Zheng GJ; Wang CG; Zhou L; Wen YM; Wang CM; Hou SX
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2005 Feb; 23(1):69-71. PubMed ID: 15804028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin loading and eluting characteristics of bioresorbable hydrogel microspheres: in vitro study.
    Weng L; Le HC; Lin J; Golzarian J
    Int J Pharm; 2011 May; 409(1-2):185-93. PubMed ID: 21382461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas.
    Jones AK; Bejugam NK; Nettey H; Addo R; D'Souza MJ
    J Drug Target; 2011 Jul; 19(6):427-33. PubMed ID: 20678033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method.
    Chen CQ; Lin W; Coombes AG; Davis SS; Illum L
    J Microencapsul; 1994; 11(4):395-407. PubMed ID: 7931939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Pharm Sci; 1989 Sep; 78(9):745-8. PubMed ID: 2585268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarithromycin targeting to lung: optimization of the size, morphology and release characteristics of albumin microspheres.
    Ozkan Y; Dikmen N; Işimer A
    Acta Pol Pharm; 2000; 57(5):375-80. PubMed ID: 11126029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method to prepare monodisperse microparticles.
    Muramatsu N; Nakauchi K
    J Microencapsul; 1998; 15(6):715-23. PubMed ID: 9818949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Microencapsul; 1990; 7(1):85-94. PubMed ID: 2308056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres.
    Narayani R; Rao KP
    J Microencapsul; 1994; 11(1):69-77. PubMed ID: 8138876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
    Defail AJ; Edington HD; Matthews S; Lee WC; Marra KG
    J Biomed Mater Res A; 2006 Dec; 79(4):954-62. PubMed ID: 16941588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug targeting: magnetically responsive albumin microspheres--a review of the system to date.
    Senyei AE; Widder KJ
    Gynecol Oncol; 1981 Aug; 12(1):1-13. PubMed ID: 7024051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.